CHUGAI PHARMACEUTICAL CO., LTD.

Print

Investor Conference on FY2018 2Q Financial Results

Date July 27, 2018
Presentations
Aiming to Achieve Mid-term Business Plan “IBI 18”
- FY2018 Half Year Results -

Tatsuro Kosaka,
President and CEO
FY2018 2Q Consolidated Financial Overview (IFRS based)
Toshiaki Itagaki,
Executive Vice President and CFO
Overview of Development Pipeline
Dr. Yasushi Ito,
Executive Vice President and Co-Head of Project & Lifecycle Management Unit

[ PDF 1MB]

  Webcasts (Japanese / English)
  To view the webcasts, please visit the websites below.

Japanese :
http://www.c-hotline.net/Viewer/Default/CHPHff7ddedb7a38d421cce2f4c56d4a660a

English :
http://www.c-hotline.net/Viewer/Default/CHPHf6e3b6c4594d00365068f3141525359d

To view PDF files,
you will need Adobe® Reader® which is available as a free download.

Close